Dual or multi-targeting inhibitors: The next generation anticancer agents NM Raghavendra, D Pingili, S Kadasi, A Mettu, S Prasad European journal of medicinal chemistry 143, 1277-1300, 2018 | 248 | 2018 |
Synthesis and biological evaluation of pyrimidine analogs as potential antimicrobial agents B Sreenivas, M Akhila, B Mohammed Intern. J. Pharm. Pharm. Sci 4, 306-310, 2012 | 14 | 2012 |
Design, synthesis, and molecular docking studies of novel pyrazolyl 2‐aminopyrimidine derivatives as HSP90 inhibitors A Mettu, V Talla, DM Bajaj, NJP Subhashini Archiv der Pharmazie 352 (10), 1900063, 2019 | 12 | 2019 |
Mechanistic investigations on substituted benzene sulphonamides as apoptosis inducing anticancer agents A Mettu, V Talla, S Thumma, SNJ Prameela Bioorganic Chemistry 95, 103539, 2020 | 11 | 2020 |
Molecular docking studies of isolated compounds from Cassia fistula on HMG-COA reductase V Reddy, SJ Anarthe, MG Raju, M Akhila, GB Raj Asian Journal of Research in Chemistry 12 (2), 89-93, 2019 | 10 | 2019 |
Novel anticancer Hsp90 inhibitor disubstituted pyrazolyl 2-aminopyrimidine compound 7t induces cell cycle arrest and apoptosis via mitochondrial pathway in MCF-7 cells A Mettu, V Talla, SJP Naikal Bioorganic & Medicinal Chemistry Letters 30 (20), 127470, 2020 | 9 | 2020 |
CACHE Challenge# 1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein F Li, S Ackloo, CH Arrowsmith, F Ban, CJ Barden, H Beck, J Beránek, ... Journal of Chemical Information and Modeling, 2024 | 2 | 2024 |
Isolation, in vitro antidiabetic, antioxidant activity and molecular docking studies of pentacyclic triterpenoids from Syzygium alternifolium(wt.) Walp bark G Suvarchala Reddy, N. V. L., Akhila, M., Subrahmanyam, C. V. S., & Trimurtulue Journal of Pharmacy and Biological Sciences 10 (6), 148-154, 2015 | | 2015 |